Life in a Clinical Trial: The Worm's Eye View
Now that I've versed you a bit on the big picture, it's time to share clinical trial life in the form of the little picture: that is, moi. Immunotherapies work differently than chemotherapies. The latter just doses you with toxic chemicals that have been shown to do a reasonably good job at killing cancer cells without killing so many healthy cells that it, well, kills you. The former helps your immune system to do its job better. For instance, the durvalumab that I take is a PD-L1 inhibitor. My understanding (and anyone who is qualified to correct me or add additional info, please do!) is that this drug stops the body ("inhibits" it, get it?) from making the kind of protein (PD-L1) that some cancer cells smear all over themselves in order to hide in plain sight. So if my cancer cells were producing a lot of PD-L1 - well, they aren't anymore. And instead, as I mentioned in the last post, the cancer cell is naked and being pointed out and laughed at. The seco...